Effect of an angiotensin II receptor antagonist, candesartan, on insulin resistance and pressor mechanisms in essential hypertension

Citation
K. Higashiura et al., Effect of an angiotensin II receptor antagonist, candesartan, on insulin resistance and pressor mechanisms in essential hypertension, J HUM HYPER, 13, 1999, pp. S71-S74
Citations number
20
Categorie Soggetti
Cardiovascular & Respiratory Systems
Journal title
JOURNAL OF HUMAN HYPERTENSION
ISSN journal
09509240 → ACNP
Volume
13
Year of publication
1999
Supplement
1
Pages
S71 - S74
Database
ISI
SICI code
0950-9240(199901)13:<S71:EOAAIR>2.0.ZU;2-L
Abstract
Candesartan (8 mg/d) was administered for 2 weeks to eight patients with es sential hypertension to investigate the effect of an angiotensin II recepto r antagonist on insulin sensitivity. The effect of candesartan on sodium-re taining action and the activation of presser systems by hyperinsulinaemia, which might be related to presser mechanisms in essential hypertension, was also investigated in this study, In patients with essential hypertension, candesartan restored insulin sensitivity to the level of that in normotensi ve subjects. Candesartan treatment attenuated the sodium-retaining action o f hyperinsulinaemia. These findings suggest that inhibition of angiotensin II action by candesartan can improve insulin sensitivity and inhibit the so dium-retaining action associated with hyperinsulinaemia in essential hypert ension.